I ndividual patients' values and preferences are critical to patient-centered decisions. When dealing with health outcomes on an interval scale, where many intermediate outcomes must be considered, it can be helpful to encourage the patient decision maker to consider what functional form may be specified and parameterized for a given outcome attribute. This assessment problem is described in Keeney and Raiffa's classic book. 1 For simplicity, let us restrict ourselves to unidimensional settings. We are asked first to specify an attitude toward risk (risk neutral, risk averse, or risk seeking) and then subclassify attitudes depending on whether the risk attitude is constant, absolutely decreasing, or relatively decreasing, in the case of the most common attitude, risk aversion. These questions then often specify a functional form for the patient's utility function, which can be parameterized on the basis of a limited number of responses from the patient decision maker. This approach tends to consider just risk aversion, the curvature of the utility function as determined by the ratio of its second to its first derivative. That curvature can be quantified by the Pratt-Arrow measure of risk aversion, 2 u 2 /u 1 , although other measures, such as the stronger Ross measure of risk aversion, [3] [4] [5] [6] are sometimes used. We use the notation u i to denote the ith derivative of u(x), d i u(x)/dx i .
For utility distribution functions, one can consider either utility density functions (udfs) or their integrals, cumulative utility functions (cufs), analogous to probability density functions (pdfs) and cumulative distribution functions (cdfs). For density functions, shape can be described by the function's moments (e.g., 0-mean, 1-slope, 2-variance, 3-skewness, 4-kurotosis, and higher unnamed moments). Normatively, utilities with positive skewness are preferred by individuals whose utility function has u 3 . 0, whereas low kurtosis should be preferred by individuals whose utility function has u 4 \ 0. 7 For cumulative functions, shape is typically described by measures of curvature or the ratio of derivatives (e.g., risk aversion, 2u 2 /u 1 , the Pratt-Arrow measure of risk aversion; prudence, 8 u 3 /u 2 ; temperance, 9 2u 4 /u 3 ; and even ''edginess,'' 10 u 5 / u 4 ). It can be difficult to visualize how these measures of curvature of the cumulative function affect the shape of the density function and how moments of the density function affect the shape of the cuf. Figure  1 shows a hypothetical density function and its corresponding cumulative distribution. Note that the first derivative of the cumulative distribution is the density function.
In this issue of Medical Decision Making (MDM), Felder and Mayrhofer 11 propose a more comprehensive consideration of risk attitude. They base their argument primarily on the recent economic literature, which has often been a source of ideas later translated to medical decision making. Over the past 2 decades, that literature introduced 2 higher moments of utility, prudence, 8 and temperance. 9 An individual is said to be risk averse if u 2 /u 1 \ 0; the more negative that ratio, the more risk averse the individual. An individual is said to be risk prudent if u 3 /u 2 . 0; the more positive that ratio, the more prudent the individual. An individual is said to be risk temperate if u 4 /u 3 \ 0; the more negative that ratio, the more temperate the individual. But, simply based on these ratios of derivatives, it is hard to visualize the shapes.
The first derivative of a typical cuf shows that it often has a positive slope (i.e., the more health or quality-adjusted life-years [QALYs] or whatever an outcome obtains for the patient, the higher his or her utility). The second derivative has a negative slope, reflecting decreasing marginal utility (i.e., the second derivative of the utility slope decreases as health increases). This often leads to cufs such as log(health) or root(health) or exp(health). Some, but not all, of these functions have defined a third derivative, which reflects prudence. Kimball 8 translates prudence into certain expected behaviors with respect to monetary risk, which he calls ''precautionary savings.'' Felder and Mayrhofer 11 and Krieger and Mayrhofer 12 explain prudence as a drive to avoid more risk if a comorbidity or independent background risk 13, 14 is present. Kimball also proposes that economic temperance (i.e., the kurtosis of udf or the ratio u 4 /u 3 ) supports behavior that separates additional risks so they are less likely to co-occur. 9 Finally, Lajeri-Chaherli 15 introduced the concept of edginess, which reflects the fifth derivative of the utility function. It remains unclear, at least to this physician, exactly what these higher-order moments reflect in economics, no less in medicine, if utilities reflect in some way quality-adjusted survival. 16 Felder and Mayrhofer 11 also introduce the concept of risk vulnerability 17,18 to medical decisions. Under risk vulnerability, risk-averse individuals behave in a more risk-averse manner when exposed to an independent unfair background risk (i.e., risk with mean \0). In the medical context, an example may be an individual who has a second chronic disease (e.g., diabetes) in the face of a disease such as cancer that requires risky treatment. The additional background risk of diabetes should make the risk-vulnerable patient less likely to undertake a risky cancer treatment. Perhaps we can refer to these moments as PTV (prudence, temperance, vulnerability). The key question for me is how PTV affects the shape of the cumulative utility curve itself because it is difficult to think in terms of higher moments of the density function.
Unfortunately, neither the economic articles nor the new article in this issue of MDM provide much intuition or even an example of what a PTV cuf utility function would look like, especially in medicine, save to say it is concave downward, as are risk-averse utility functions. We know that the first derivative of a utility function (u 1 ) describes its slope and the second derivative (u 2 ) describes the rate of change of slope. In a typical utility function, u(x), the slope is positive and u 2 is negative if the individual is risk averse. A risk-averse utility function is concave downward, and the expectation of a gamble as a certain outcome is preferred to the gamble. The difference in utility between the certain outcome (the certainty equivalent) and the gamble is called the risk (or insurance) premium. When an individual has a risk-averse utility function, the higher his or her risk premium; conversely, the lower his or her certainty equivalent for a given lottery.
Another way to describe risk aversion is to say the risk premium p . 0; the greater the value of p, the more risk averse the individual. Felder and Mayrhofer 11 note that constant risk-averse utility functions (e.g., 1 -e -rt ) do not exhibit risk vulnerability. An individual is said to be prudent if the prudence Figure 1 These sample utility density and cumulative utility distributions were generated from the log-normal skewed distribution, which may affect the cumulative utility function. They demonstrate that it is difficult to intuit the shape of the cumulative utility function from the moments of the utility density functions. Mean (first moment) is 5.48; variance (second moment), 5.87; skewness (third moment), 6.16; kurtosis, (fourth moment), 110.9.
index P = u 3 /u 2 is .0 and temperate if the temperance index T = u 4 /u #3 is \0. (Note the alternating signs, the marker for risk vulnerability, and as is the relation that T . P . A, the Pratt-Arrow measure.) These measures of risk attitude require that the utility function be 4fold differentiable, as has been noted in the economic literature. Because not all interval scale utility functions are 4-fold differentiable (especially in settings with discrete outcomes), it is unclear how widely applicable PTV may be in medical decision making. Risk vulnerability requires risk aversion and prudence.
Normatively, risk-vulnerable individuals will evidence increased aversion to risk when an additional unfair background risk is introduced. Such individuals evidence precautionary savings; that is, they insure themselves against that additional risk by increasing savings. Although Felder and Mayrhofer 11 do not provide the reader with much medical intuition about PTV, one may imagine that one medical equivalent may be to opt for more preventative behaviors, a healthier lifestyle, or even to buy more health insurance.
The effect of PTV on cuf shape is hard to visualize. Felder and Mayrhofer 11 suggest that the introduction of skew and sufficient kurtosis in the density function will shift thresholds to the left (i.e., to lower probabilities). But we need both data from utility assessment in real medical problems and further analytic examination of just which functional forms are affected, by how much, and what kinds of assessment questions in medicine will identify PTV individuals.
Felder and Mayrhofer 11 suggest that PTV individuals will further avoid risk if they face comorbidity, as many chronically ill patients do. In temperate patients, Kimball suggests that there is a strong tendency to separate risks, but it is not clear what separating will look like in medicine. In one study, Krieger and Mayrhofer 12 found little effect of temperance among physicians, mirroring what Deck 18, 19 reported in economic studies.
Felder and Mayrhofer 11 show how PTV lowers the therapeutic and diagnostic thresholds that we described in a simple model 3 decades ago. 20, 21 PTV also lowers the optimal cutoffs in a test receiveroperating characteristic curve. Their new analysis follows one of their working papers 22 quite closely, although that paper emphasizes the effects of temperance as opposed to risk vulnerability.
Although their papers (including its examples) are largely theoretical, if these new utility moments hold in medical choice, then exploring patients' utility spaces for PTV may be important. Because these higher-order shape measures of utility function affect the diagnostic and therapeutic thresholds (one of the simplest models of a medical choice), we can anticipate that they also may affect the optimal choice in more complex models.
Finally, the joint effects of PTV on utility function when combined with their economic effects in costutility analysis may provide key insights into the efficient use of resources and the conflicts between individual and societal choice. Although these models are normative, they also may help describe how patients and clinicians behave. In an examination of how a small group of physicians reacted to a set of theoretical scenarios, Krieger and Mayrhofer 12 observed some evidence of prudence and risk vulnerability but less evidence of temperance. Prior work has examined the effects of risk aversion 23 and comorbidity 13 on medical decisions. Recently, there has been a resurgence of interest in the threshold models. Djulbegovic 24 explored the effect of regret and dual system reasoning on thresholds.
There remains much work to be done to determine whether and how these higher-order measures affect optimal normative decisions in medicine. The place to start is likely to be using the QALY utility functions. 16 The translation of PTV into medicine is likely best done by a team that includes investigators versed in mathematics, economics, decision science, and medicine. The addition of a clinician to the team may smooth the transition. Among the first tasks will be the development of techniques for assessing PTV in a medical context. Prudence, temperance, and risk vulnerability could be major influences in medical decision making, but for now, this is an open question. Let the games begin.
